Tissue plasminogen activator (tPA) administered within 4.5 h of symptom onset restores
cerebral blood flow (CBF) and promotes neurological recovery of stroke patients. However …

PURPOSE: The aim of this study was to estimate the prevalence of elevated blood pressure
in adult patients with acute stroke in the United States (US). METHODS: Patients with stroke …

Coronary revascularization is the most important strategy for coronary artery disease. This
review summarizes the current most prevalent approaches for coronary revascularization …

This chapter about fibrinolytic, antiplatelet, and antithrombin treatment for acute ST-segment
elevation (STE) myocardial infarction (MI) is part of the American College of Chest …

Objective Previous data on young patients with acute coronary syndrome (ACS) have
indicated higher rates of normal coronary angiograms but higher mortality in women than …

Pulmonary embolism (PE) is a major cause of morbidity and mortality world-wide, and the
use of thrombolytic therapy has been associated with favourable clinical outcomes in certain …

Background and Purpose—Stroke is a serious complication after acute myocardial infarction
(AMI) and is closely associated with decreased survival. This study aimed to investigate the …

Background Acute myocardial infarction (AMI) with no evidence of relevant stenosis of the
coronary artery, known as myocardial infarction (MI) with nonobstructive coronary arteries …

Fibrinolytic agents provide an important alternative therapeutic strategy in individuals
presenting with ST-elevation myocardial infarction (STEMI). Ultimately, primary …

Recurrent ischemic events after an acute coronary syndrome (ACS) remain common.
Antithrombotic therapy with coronary revascularization reduces the frequency of such life …